NCT03155295

Brief Summary

The purpose of the study is to evaluate patient-specific surgical simulation by permitting pre-operative rehearsals, in the form of the surgeon completing a dry run of the procedure on a model constructed from the patient's radiological studies that replicates every aspect of their organs. The investigators' aim is to evaluate the effectiveness of this form of practice in optimizing intraoperative and postoperative outcomes . The investigators hope eventually to use these rehearsals as a standard study tool for surgical training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

October 12, 2017

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

5.3 years

First QC Date

May 10, 2017

Last Update Submit

February 8, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Warm ischemia time measured during minimal invasive partial nephrectomy surgery

    Warm ischemia time is reported on completion of minimal invasive partial nephrectomy surgery, the metric will be measured in minutes as a continuous variable.

    At the end of each surgical procedure, approximately 24 hours after surgery

  • Estimated blood loss measured during minimal invasive partial nephrectomy surgery

    Estimated blood loss is reported on completion of minimal invasive partial nephrectomy surgery, it is estimated by the volume of fluid in the suction irrigation at the end of surgery and measured in ml as a continuous variable.

    At the end of each surgical procedure, approximately 24 hours after surgery

  • Change in postoperative renal functions

    The difference between preoperative (within a week prior to surgery) and postoperative (12 hours , 1 day and 30 days after surgery) using estimated GFR measured through serum creatinine blood test.

    Zero at date of randomization and serial measurements at 12 hours , 1 day and 30 days after surgery

  • Surgical complications

    Intraoperative and postoperative complications will be measured and reported using the modified Clavien-Dindo classification of surgical complications (Grade 1 to 5).

    From date of surgery up to 30 days postoperative, every complication encountered during that time will be recorded

  • Objective evaluation of surgical performance

    All surgical cases will be recorded and reviewed by a third party online tool that specializes in evaluation of surgical performance using the GEARS (Global Evaluative Assessment of Robotic Skills) tool

    At the end of each surgical procedure, approximately 24 hours after surgery

  • Operative time measured during minimal invasive partial nephrectomy surgery

    Operative time is reported on completion of minimal invasive partial

    At the end of each surgical procedure, approximately 24 hours after surgery

Secondary Outcomes (4)

  • Positive margins of the tumor specimen

    From date of randomization up to 10 days after surgery

  • Change in the volume of ratio of red blood cells to total blood volume (HCT)

    Zero at date of randomization and serial measurements at 12 and 24 hours after surgery

  • Hospital stay

    From date of admission up to 30 days after surgery

  • Hospital readmission

    From date of surgery up to 30 days postoperative, every hospital readmission encountered during that time will be recorded

Study Arms (2)

Physical reality simulation (rehearsal)

Using 3-D printing and polymer technology, the investigators will construct patient specific simulated hydrogel models designed from patients' imaging, incorporating the necessary anatomy, physiology and pathology specific to each patient. Participants with patients assigned to preoperative rehearsal will undergo pre-operative simulation only once.

Other: Physical reality simulation

Virtual reality simulation

The DaVinci surgical skills simulator (DVSSS) uses a virtual reality surgical simulation platform that encompasses a variety of basic exercises specifically designed to give users the opportunity to improve their proficiency with the da Vinci surgeon console controls and basic robotic surgical skills. Participants with patients assigned to preoperative simulation will complete a refresher module on the Virtual reality simulator.

Other: Virtual reality simulation

Interventions

Using 3-D printing and polymer technology, the investigators will construct patient specific simulated hydrogel models designed from patients' imaging, incorporating the necessary anatomy, physiology and pathology specific to each patient. These models are constructed at the Laboratory for Simulation-based Translational Research at the Department of Urology. Group 1 urologists will rehearse the minimally-invasive partial nephrectomy (MIPN) surgery using these patient-specific models.

Physical reality simulation (rehearsal)

The DaVinci surgical skills simulator system uses a virtual reality surgical simulation platform that encompasses a variety of basic exercises specifically designed to give users the opportunity to improve their proficiency with the da Vinci surgeon console controls and basic robotic surgical skills. All urologists have already completed a basic robotic skills curriculum. Group 2 urologists will complete a refresher module on the virtual reality simulator.

Virtual reality simulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population is comprised of 100 minimally invasive partial nephrectomy (MIPN) patients), 5 faculty expert urologists, and 5 trainees including four urology residents and one endourology fellow.

You may qualify if:

  • All patients scheduled to undergo MIPN surgery at the University of Rochester Medical Center
  • Ability to give informed consent
  • Willing to participate in the study
  • Any racial or ethnic origin

You may not qualify if:

  • Inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester Medical Center

Rochester, New York, 14642, United States

Location

Study Officials

  • Ahmed Ghazi, MD

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 10, 2017

First Posted

May 16, 2017

Study Start

October 12, 2017

Primary Completion

January 31, 2023

Study Completion

January 31, 2023

Last Updated

February 10, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations